Elias Bou Farhat (@boufarhat_elias) 's Twitter Profile
Elias Bou Farhat

@boufarhat_elias

Postdoctoral Research Fellow @DanaFarber @BrighamWomens | @AUB_Lebanon M.D '22 | Interested in CT surgery

ID: 1538068033557635073

calendar_today18-06-2022 07:56:35

81 Tweet

56 Followers

27 Following

Journal for ImmunoTherapy of Cancer (@jitcancer) 's Twitter Profile Photo

Meet the Author: Amin H. Nassar (Amin Nassar, MD), a medical oncology fellow from Yale Cancer Center, is co-1st author of “Clinical Outcomes and Safety of Immune Checkpoint Inhibitors in Patients with Solid Tumors and Paraneoplastic Syndromes,” recently published in #JITC! 1/6

Meet the Author: Amin H. Nassar (<a href="/AminNassarMD/">Amin Nassar, MD</a>), a medical oncology fellow from <a href="/YaleCancer/">Yale Cancer Center</a>, is co-1st author of “Clinical Outcomes and Safety of Immune Checkpoint Inhibitors in Patients with Solid Tumors and Paraneoplastic Syndromes,” recently published in #JITC! 1/6
Yale Cardiology (@yalecardiology) 's Twitter Profile Photo

"Caring for patients is both humbling and rewarding. You meet patients in their most vulnerable state, and they often trust you with their most valuable assets—their body and their loved ones." Learn about #cardiology clinical fellow Sarah Abou Alaiwi, MD, medicine.yale.edu/internal-medic…

Amin Nassar, MD (@aminnassarmd) 's Twitter Profile Photo

So proud of Ritu Yale Internal Medicine for presenting our work regarding ALK consolidation treatment in stage 3 ALK + unresectable NSCLC! What a packed room! More to come from this study soon Mark D. Siegel ASCO Rafeh Naqash, MD

So proud of Ritu <a href="/YaleIMed/">Yale Internal Medicine</a> for presenting our work regarding ALK consolidation treatment in stage 3 ALK + unresectable NSCLC! What a packed room! More to come from this study soon

<a href="/MarkDSiegel1/">Mark D. Siegel</a> <a href="/ASCO/">ASCO</a> <a href="/thenasheffect/">Rafeh Naqash, MD</a>
Elias Bou Farhat (@boufarhat_elias) 's Twitter Profile Photo

Excited to share our latest expert editorial in ASCO Daily News! Dive into our insights on the advantages of NGS in detecting mismatch repair deficiency (MMR-D). Kudos to Amin Nassar, MD , Rafeh Naqash, MD and #DJK! dailynews.ascopubs.org/do/identifying…

Sarah Abou Alaiwi (@sarahaboualaiwi) 's Twitter Profile Photo

Very fortunate to have the chance to write this with Katherine Clark Godiksen #MatthewColna we are far from routinely and efficiently assessing CRF Yale Cardiology We Have More Steps Along the Path to Routine Cardiorespiratory Fitness Evaluation | JACC: Advances jacc.org/doi/10.1016/j.…

Amin Nassar, MD (@aminnassarmd) 's Twitter Profile Photo

Delighted to share "Precision Medicine Strategies for Monitoring Treatment Response and Testing MRD in NSCLC" | VuMedi vumedi.com/video/precisio… via @vumedi

Samer Salem (@samersalem18) 's Twitter Profile Photo

Hi #MedTwitter! I’m Samer Salem, an #IMG from Lebanon researching Kidney Cancer at Brigham and Women's Hospital and applying for Internal Medicine residency. So excited to pursue my dream specialty! #Match2025 #InternalMedicine AAMC ID: 14538528

Hi #MedTwitter! I’m Samer Salem, an #IMG from Lebanon researching Kidney Cancer at <a href="/BrighamWomens/">Brigham and Women's Hospital</a> and applying for Internal Medicine residency. So excited to pursue my dream specialty! #Match2025 #InternalMedicine 

AAMC ID: 14538528
Elio Adib (@adib_elio) 's Twitter Profile Photo

1/🧵Our study in JTO & JTO CRR CRR examining TMB/PD-L1 expression & outcomes in patients w/ NSCLC and new 🧠 mets receiving 🧠-directed ☢️ + immunotherapy. Grateful to collaborate with amazing colleagues Dana-Farber Brigham and Women’s Radiation Oncology Brigham and Women's Neurosurgery #lcsm jtocrr.org/article/S2666-…

OncoAlert (@oncoalert) 's Twitter Profile Photo

Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study out on JITC buff.ly/iFnRFbO This retrospective, multicenter study examined the safety and clinical outcomes of 110

Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study out on JITC

buff.ly/iFnRFbO 

This retrospective, multicenter study examined the safety and clinical outcomes of 110
Amin Nassar, MD (@aminnassarmd) 's Twitter Profile Photo

Introducing Curvia — a global mentorship platform connecting ambitious students with top-tier researchers to unlock their full potential. 💡 Get published. 🧬 Learn research from the ground up. 🌍 Build your future with dedicated mentors. 🔗 curvia.org |

Elias Bou Farhat (@boufarhat_elias) 's Twitter Profile Photo

Congratulations to Amin Nassar, MD and Rafeh Naqash, MD —it’s an honor to work under your mentorship. Wishing you continued success; the sky is not the limit, it’s just the beginning

Amin Nassar, MD (@aminnassarmd) 's Twitter Profile Photo

Thrilled for Rafeh Naqash, MD on his latest grant win! A true force of nature—brilliant, humble, and always lifting others, even in their darkest moments! Grateful to call him a friend and mentor. #inspiration #gratitude

Curvia (@curviallc) 's Twitter Profile Photo

🎓 Tired of outdated study methods and slow progress? 📷 Join curvia.org— where students fast-track success with expert-curated resources. 📷 Learn at your pace 📷 Real results, real fast 📷

Curvia (@curviallc) 's Twitter Profile Photo

👩‍🔬 Students, are you ready to elevate your research journey? Join #Curvia.org and connect with top mentors in oncology & tumor immunology. Research. Publish. Network. 🚀 📍 Sign up now at Curvia.org! #CancerResearch #Oncology #MedicalStudents #ResearchOpportunities